Kiromic BioPharma amends bylaws to set stockholder meeting quorum at one-third of outstanding shares

Kiromic Biopharma, Inc.

Quorum reduced to 33.33% of issued and outstanding shares entitled to vote.
Amendment approved by Board on July 17, 2023 and effective immediately.
Change intended to improve the Company's ability to hold stockholder meetings.
No other changes to Bylaws were made.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Kiromic Biopharma, Inc.: Amended bylaws to reduce quorum for stockholder meetings to one-third of shares outstanding (effective 2023-07-17).

Change: bylaw amendment
Effective: 2023-07-17

Exact text from the filing

On July 17, 2023, the Board of Directors of Kiromic BioPharma, Inc. (the “Company”) approved an amendment of the Company’s Bylaws (the “Bylaws”) to change the quorum for stockholder meetings to equal one-third (33.33%) of the shares issued and outstanding and entitled to vote on the matters at the meeting.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001558370-23-011954

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.